Works by Seto, Takashi

Results: 120

W'ALK' Into the Next Stage.

Published in:

2017

By:

Gouji Toyokawa;
Takashi Seto;
Mitsuhiro Takenoyama;
Yukito Ichinose;
Toyokawa, Gouji;
Seto, Takashi;
Takenoyama, Mitsuhiro;
Ichinose, Yukito

Publication type:

journal article

The Kuroshio large meander and its various impacts: a review.

Published in:

Journal of Oceanography, 2025, v. 81, n. 3, p. 165, doi. 10.1007/s10872-025-00753-z

By:

Hirata, Hidetaka;
Nishikawa, Hatsumi;
Usui, Norihisa;
Miyama, Toru;
Sugimoto, Shusaku;
Kusaka, Akira;
Seto, Takashi

Publication type:

Article

Persistent and Aggressive Treatment for Thymic Carcinoma.

Published in:

Oncology, 2006, v. 70, n. 5, p. 325, doi. 10.1159/000097944

By:

Maruyama, Riichiroh;
Suemitsu, Ryuichi;
Okamoto, Tatsuro;
Kojo, Miyako;
Aoki, Yoshiro;
Wataya, Hiroshi;
Eguchi, Takashi;
Nishiyama, Kenichi;
Seto, Takashi;
Ichinose, Yukito

Publication type:

Article

Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503.

Published in:

Quality of Life Research, 2023, v. 32, n. 9, p. 2629, doi. 10.1007/s11136-023-03424-y

By:

Matsuda, Ayako;
Yamaoka, Kazue;
Kunitoh, Hideo;
Seto, Takashi;
Tsuboi, Masahiro;
Ohira, Tatsuo;
Maruyama, Riichiroh;
Okamoto, Hiroaki;
Kubota, Kaoru

Publication type:

Article

Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.

Published in:

Japanese Journal of Clinical Oncology, 2020, v. 50, n. 3, p. 318, doi. 10.1093/jjco/hyz179

By:

Yamaguchi, Masafumi;
Hirata, Hideki;
Ebi, Noriyuki;
Araki, Jun;
Seto, Takashi;
Maruyama, Riichiroh;
Akamine, Shinji;
Inoue, Yuichi;
Semba, Hiroshi;
Sasaki, Jiichiro;
Okamoto, Tatsuro

Publication type:

Article

Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancer.

Published in:

Japanese Journal of Clinical Oncology, 2018, v. 48, n. 1, p. 31, doi. 10.1093/jjco/hyx144

By:

Takashi Seto;
Fumihiko Hirai;
Hideo Saka;
Yoshihito Kogure;
Kiyotaka Yoh;
Seiji Niho;
Kenjiro Fukase;
Hitoshi Shimada;
Michitaka Sasai;
Koichi Fukino

Publication type:

Article

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2017, v. 47, n. 7, p. 618, doi. 10.1093/jjco/hyx045

By:

Toyoaki Hida;
Miyako Satouchi;
Kazuhiko Nakagawa;
Takashi Seto;
Shingo Matsumoto;
Katsuyuki Kiura;
Hiroshi Nokihara;
Haruyasu Murakami;
Kota Tokushige;
Ben Hatano;
Makoto Nishio

Publication type:

Article

Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients.

Published in:

Japanese Journal of Clinical Oncology, 2016, v. 46, n. 5, p. 462, doi. 10.1093/jjco/hyw014

By:

Akira Inoue;
Kazushi Yoshida;
Satoshi Morita;
Fumio Imamura;
Takashi Seto;
Isamu Okamoto;
Kazuhiko Nakagawa;
Nobuyuki Yamamoto;
Satoshi Muto;
Masahiro Fukuoka

Publication type:

Article

Amrubicin as Second-line and Beyond Treatment for Platinum-refractory Advanced Thymic Carcinoma.

Published in:

Japanese Journal of Clinical Oncology, 2013, v. 43, n. 10, p. 1018, doi. 10.1093/jjco/hyt106

By:

Hirai, Fumihiko;
Seto, Takashi;
Yamanaka, Takeharu;
Toyozawa, Ryo;
Inamasu, Eiko;
Kojo, Miyako;
Toyokawa, Gouji;
Morodomi, Yosuke;
Shiraishi, Yoshimasa;
Takenaka, Tomoyoshi;
Yamaguchi, Masafumi;
Takenoyama, Mitsuhiro;
Ichinose, Yukito

Publication type:

Article

LKB1 Mutations Frequently Detected in Mucinous Bronchioloalveolar Carcinoma.

Published in:

Japanese Journal of Clinical Oncology, 2011, v. 41, n. 9, p. 1132, doi. 10.1093/jjco/hyr102

By:

Osoegawa, Atsushi;
Kometani, Takuro;
Nosaki, Kaname;
Ondo, Kaoru;
Hamatake, Motoharu;
Hirai, Fumihiko;
Seto, Takashi;
Sugio, Kenji;
Ichinose, Yukito

Publication type:

Article

Phase I Study of Topotecan and Cisplatin in Patients with Small Cell Lung Cancer.

Published in:

Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 197, doi. 10.1093/jjco/hyq177

By:

Ichinose, Yukito;
Seto, Takashi;
Nishiwaki, Yutaka;
Kiura, Katsuyuki;
Sakai, Hiroshi;
Yokoyama, Akira;
Segawa, Yoshihiko;
Ando, Masahiro;
Watanabe, Koshiro

Publication type:

Article

Randomized Phase 2 Dose-finding Study of Weekly Administration of Darbepoetin Alfa in Anemic Patients with Lung or Ovarian Cancer Receiving Multicycle Platinum-containing Chemotherapy.

Published in:

Japanese Journal of Clinical Oncology, 2010, v. 40, n. 6, p. 521, doi. 10.1093/jjco/hyq017

By:

Ichinose, Yukito;
Seto, Takashi;
Nishiwaki, Yutaka;
Ohe, Yuichiro;
Yamada, Yoshiharu;
Takeda, Koji;
Saijo, Nagahiro;
Hotta, Tomomitsu

Publication type:

Article

Patient-Perceived Barriers to the Psychological Care of Japanese Patients with Lung Cancer†.

Published in:

Japanese Journal of Clinical Oncology, 2008, v. 38, n. 10, p. 653, doi. 10.1093/jjco/hyn088

By:

Endo, Chiharu;
Akechi, Tatsuo;
Okuyama, Toru;
Seto, Takashi;
Kato, Masashi;
Seki, Nobuhiko;
Eguchi, Kenji;
Hosaka, Takashi;
Furukawa, Toshiaki A.

Publication type:

Article

The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.

Published in:

2015

By:

Nosaki, Kaname;
Seto, Takashi

Publication type:

journal article

A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.

Published in:

2018

By:

Sasaki, Tomonari;
Seto, Takashi;
Yamanaka, Takeharu;
Kunitake, Naonobu;
Shimizu, Junichi;
Kodaira, Takeshi;
Nishio, Makoto;
Kozuka, Takuyo;
Takahashi, Toshiaki;
Harada, Hideyuki;
Yoshimura, Naruo;
Tsutsumi, Shinichi;
Kitajima, Hiromoto;
Kataoka, Masaaki;
Ichinose, Yukito;
Nakagawa, Kazuhiko;
Nishimura, Yasumasa;
Yamamoto, Nobuyuki;
Nakanishi, Yoichi

Publication type:

journal article

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.

Published in:

Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0382-3

By:

Yamaguchi, Masafumi;
Hirai, Fumihiko;
Taguchi, Kenichi;
Toyozawa, Ryo;
Edagawa, Makoto;
Shimamatsu, Shinichiro;
Nosaki, Kaname;
Seto, Takashi;
Takenoyama, Mitsuhiro;
Ichinose, Yukito

Publication type:

Article

Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.965741

By:

Shinkichi Takamori;
Takashi Seto;
Masafumi Yamaguchi;
Fumihiko Kinoshita;
Takatoshi Fujishita;
Kensaku Ito;
Ryo Toyozawa;
Fumihiro Shoji;
Tatsuro Okamoto

Publication type:

Article

Risk Factors for a Second Episode of Hemoptysis.

Published in:

Clinical Medicine: Circulatory, Respiratory & Pulmonary Medicine, 2009, v. 3, p. 1, doi. 10.4137/CCRPM.S1064

By:

Seki, Nobuhiko;
Shiozaki, Go;
Ota, Mayuko;
Ota, Shuji;
Seki, Reishi;
Seto, Takashi;
Uematsu, Kazutsugu;
Eguchi, Kenji

Publication type:

Article

Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.

Published in:

International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x

By:

Nosaki, Kaname;
Yoh, Kiyotaka;
Toyozawa, Ryo;
Horinouchi, Hidehito;
Morise, Masahiro;
Ohashi, Kadoaki;
Murakami, Haruyasu;
Satouchi, Miyako;
Sakakibara-Konishi, Jun;
Yano, Seiji;
Okumura, Fumihiko;
Matsumoto, Shingo;
Shimokawa, Mototsugu;
Seto, Takashi;
Goto, Koichi

Publication type:

Article

Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.

Published in:

2023

By:

Sugawara, Shunichi;
Kondo, Masashi;
Yokoyama, Toshihide;
Kumagai, Toru;
Nishio, Makoto;
Goto, Koichi;
Nakagawa, Kazuhiko;
Seto, Takashi;
Yamamoto, Nobuyuki;
Kudou, Kentarou;
Asato, Takayuki;
Zhang, Pingkuan;
Ohe, Yuichiro

Publication type:

Correction Notice

Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.

Published in:

2022

By:

Sugawara, Shunichi;
Kondo, Masashi;
Yokoyama, Toshihide;
Kumagai, Toru;
Nishio, Makoto;
Goto, Koichi;
Nakagawa, Kazuhiko;
Seto, Takashi;
Yamamoto, Nobuyuki;
Kudou, Kentarou;
Asato, Takayuki;
Zhang, Pingkuan;
Ohe, Yuichiro

Publication type:

Correction Notice

Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study.

Published in:

International Journal of Clinical Oncology, 2022, v. 27, n. 12, p. 1828, doi. 10.1007/s10147-022-02232-7

By:

Sugawara, Shunichi;
Kondo, Masashi;
Yokoyama, Toshihide;
Kumagai, Toru;
Nishio, Makoto;
Goto, Koichi;
Nakagawa, Kazuhiko;
Seto, Takashi;
Yamamoto, Nobuyuki;
Kudou, Kentarou;
Asato, Takayuki;
Zhang, Pingkuan;
Ohe, Yuichiro

Publication type:

Article

Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405).

Published in:

International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1404, doi. 10.1007/s10147-022-02193-x

By:

Haratake, Naoki;
Shimokawa, Mototsugu;
Seto, Takashi;
Yoshioka, Hiroshige;
Yamamoto, Nobuyuki;
Nakagawa, Kazuhiko;
Mitsudomi, Tetsuya

Publication type:

Article

Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101).

Published in:

International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2216, doi. 10.1007/s10147-021-02012-9

By:

Yamaguchi, Masafumi;
Tada, Hirohito;
Mitsudomi, Tetsuya;
Seto, Takashi;
Yokoi, Kohei;
Katakami, Nobuyuki;
Nakagawa, Kazuhiko;
Oda, Makoto;
Ohta, Mitsunori;
Sawa, Toshiyuki;
Yamashita, Motohiro;
Iked, Norihiko;
Saka, Hideo;
Higashiyama, Masahiko;
Nomori, Hiroaki;
Semba, Hiroshi;
Negoro, Shunichi;
Chiba, Yasutaka;
Shimokawa, Mototsugu;
Fukuoka, Masahiro

Publication type:

Article

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.

Published in:

International Journal of Clinical Oncology, 2019, v. 24, n. 5, p. 485, doi. 10.1007/s10147-019-01396-z

By:

Sugawara, Shunichi;
Nakagawa, Kazuhiko;
Yamamoto, Nobuyuki;
Nokihara, Hiroshi;
Ohe, Yuichiro;
Nishio, Makoto;
Takahashi, Toshiaki;
Goto, Koichi;
Maemondo, Makoto;
Ichinose, Yukito;
Seto, Takashi;
Sakai, Hiroshi;
Gemma, Akihiko;
Imamura, Fumio;
Shingyoji, Masato;
Saka, Hideo;
Inoue, Akira;
Takeda, Koji;
Okamoto, Isamu;
Kiura, Katsuyuki

Publication type:

Article

Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0

By:

Yamamoto, Noboru;
Goto, Koichi;
Nishio, Makoto;
Chikamori, Kenichi;
Hida, Toyoaki;
Maemondo, Makoto;
Katakami, Nobuyuki;
Kozuki, Toshiyuki;
Yoshioka, Hiroshige;
Seto, Takashi;
Tajima, Kosei;
Tamura, Tomohide

Publication type:

Article

Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.

Published in:

2017

By:

Yamamoto, Noboru;
Goto, Koichi;
Nishio, Makoto;
Chikamori, Kenichi;
Hida, Toyoaki;
Maemondo, Makoto;
Katakami, Nobuyuki;
Kozuki, Toshiyuki;
Yoshioka, Hiroshige;
Seto, Takashi;
Tajima, Kosei;
Tamura, Tomohide

Publication type:

Erratum

Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.

Published in:

International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 601, doi. 10.1007/s10147-013-0619-5

By:

Toyokawa, Gouji;
Takenoyama, Mitsuhiro;
Hirai, Fumihiko;
Toyozawa, Ryo;
Inamasu, Eiko;
Kojo, Miyako;
Morodomi, Yosuke;
Shiraishi, Yoshimasa;
Takenaka, Tomoyoshi;
Yamaguchi, Masafumi;
Shimokawa, Mototsugu;
Seto, Takashi;
Ichinose, Yukito

Publication type:

Article

Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data.

Published in:

Oncology Research & Treatment, 2015, v. 38, n. 6, p. 291, doi. 10.1159/000430852

By:

Toyokawa, Gouji;
Seto, Takashi

Publication type:

Article

Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART‐1501 study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 17, p. 2499, doi. 10.1111/1759-7714.14586

By:

Fukuda, Minoru;
Yamaguchi, Masafumi;
Yamazaki, Takuya;
Funaki, Soichiro;
Mukae, Hiroshi;
Fukuoka, Junya;
Nabeshima, Kazuki;
Tateyama, Hisashi;
Ashizawa, Kazuto;
Tomiyama, Noriyuki;
Hara, Masaki;
Seto, Takashi;
Okumura, Meinoshin;
Sugio, Kenji

Publication type:

Article

Erlotinib with or without bevacizumab as a first‐line therapy for patients with advanced nonsquamous epidermal growth factor receptor‐positive non‐small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 15, p. 2192, doi. 10.1111/1759-7714.14541

By:

Hosomi, Yukio;
Seto, Takashi;
Nishio, Makoto;
Goto, Koichi;
Yamamoto, Noboru;
Okamoto, Isamu;
Tajima, Kosei;
Kajihara, Yusuke;
Yamamoto, Nobuyuki

Publication type:

Article

Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy.

Published in:

Thoracic Cancer, 2021, v. 12, n. 23, p. 3286, doi. 10.1111/1759-7714.14200

By:

Matsubara, Taichi;
Takamori, Shinkichi;
Fujishita, Takatoshi;
Toyozawa, Ryo;
Ito, Kensaku;
Yamaguchi, Masafumi;
Seto, Takashi;
Okamoto, Tatsuro

Publication type:

Article

Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab.

Published in:

Thoracic Cancer, 2021, v. 12, n. 14, p. 2122, doi. 10.1111/1759-7714.14011

By:

Shinkichi Takamori;
Nobuki Furubayashi;
Kenichi Taguchi;
Taichi Matsubara;
Takatoshi Fujishita;
Kensaku Ito;
Masafumi Yamaguchi;
Ryo Toyozawa;
Takashi Seto;
Takahito Negishi;
Motonobu Nakamura;
Tatsuro Okamoto

Publication type:

Article

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation.

Published in:

Thoracic Cancer, 2021, v. 12, n. 6, p. 978, doi. 10.1111/1759-7714.13871

By:

Takamori, Shinkichi;
Matsubara, Taichi;
Fujishita, Takatoshi;
Ito, Kensaku;
Toyozawa, Ryo;
Seto, Takashi;
Yamaguchi, Masafumi;
Okamoto, Tatsuro

Publication type:

Article

Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient.

Published in:

Thoracic Cancer, 2020, v. 11, n. 12, p. 3605, doi. 10.1111/1759-7714.13697

By:

Takamori, Shinkichi;
Takenoyama, Mitsuhiro;
Matsubara, Taichi;
Fujishita, Takatoshi;
Ito, Kensaku;
Yamaguchi, Masafumi;
Toyozawa, Ryo;
Seto, Takashi;
Okamoto, Tatsuro

Publication type:

Article

Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2020, v. 11, n. 7, p. 2056, doi. 10.1111/1759-7714.13494

By:

Takamori, Shinkichi;
Seto, Takashi;
Jinnouchi, Mikako;
Matsubara, Taichi;
Haratake, Naoki;
Miura, Naoko;
Toyozawa, Ryo;
Yamaguchi, Masafumi;
Takenoyama, Mitsuhiro

Publication type:

Article

S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART‐1501.

Published in:

Thoracic Cancer, 2020, v. 11, n. 3, p. 693, doi. 10.1111/1759-7714.13319

By:

Fukuda, Minoru;
Funaki, Soichiro;
Yamazaki, Takuya;
Sato, Shuntaro;
Mukae, Hiroshi;
Takenoyama, Mitsuhiro;
Fukuoka, Junya;
Nabeshima, Kazuki;
Tateyama, Hisashi;
Ashizawa, Kazuto;
Hara, Masaki;
Seto, Takashi;
Okumura, Meinoshin;
Sugio, Kenji

Publication type:

Article

Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients.

Published in:

Thoracic Cancer, 2019, v. 10, n. 9, p. 1779, doi. 10.1111/1759-7714.13143

By:

Haratake, Naoki;
Seto, Takashi;
Takamori, Shinkichi;
Toyozawa, Ryo;
Nosaki, Kaname;
Miura, Naoko;
Ohba, Taro;
Toyokawa, Gouji;
Taguchi, Kenichi;
Yamaguchi, Masafumi;
Shimokawa, Mototsugu;
Takenoyama, Mitsuhiro

Publication type:

Article

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene.

Published in:

Thoracic Cancer, 2018, v. 9, n. 5, p. 563, doi. 10.1111/1759-7714.12616

By:

Kometani, Takuro;
Sugio, Kenji;
Osoegawa, Atsushi;
Seto, Takashi;
Ichinose, Yukito

Publication type:

Article

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu ( LOGIK1004 A).

Published in:

Thoracic Cancer, 2017, v. 8, n. 1, p. 40, doi. 10.1111/1759-7714.12407

By:

Fukuda, Minoru;
Shimada, Midori;
Kitazaki, Takeshi;
Nagashima, Seiji;
Hashiguchi, Kohji;
Ebi, Noriyuki;
Takayama, Koichi;
Nakanishi, Yoichi;
Semba, Hiroshi;
Harada, Taishi;
Seto, Takashi;
Okamoto, Isamu;
Ichinose, Yukito;
Sugio, Kenji

Publication type:

Article

Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).

Published in:

Thoracic Cancer, 2016, v. 7, n. 4, p. 467, doi. 10.1111/1759-7714.12360

By:

Fukuda, Minoru;
Suetsugu, Takayuki;
Shimada, Midori;
Kitazaki, Takeshi;
Hashiguchi, Kohji;
Kishimoto, Junji;
Harada, Taishi;
Seto, Takashi;
Ebi, Noriyuki;
Takayama, Koichi;
Sugio, Kenji;
Semba, Hiroshi;
Nakanishi, Yoichi;
Ichinose, Yukito

Publication type:

Article

Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report.

Published in:

Oxford Medical Case Reports, 2020, v. 20, n. 4/5, p. 1, doi. 10.1093/omcr/omaa026

By:

Miura, Naoko;
Matsubara, Taichi;
Takamori, Shinkichi;
Haratake, Naoki;
Toyozawa, Ryo;
Yamaguchi, Masafumi;
Seto, Takashi;
Taguchi, Kenichi;
Takenoyama, Mitsuhiro

Publication type:

Article

Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

Published in:

2021

By:

Yamamoto, Nobuyuki;
Harada, Hideyuki;
Okamoto, Isamu;
Masuda, Noriyuki;
Hayakawa, Kazushige;
Satouchi, Miyako;
Soejima, Toshinori;
Nishio, Makoto;
Kozuka, Takuyo;
Takeda, Koji;
Tanaka, Masahiro;
Seto, Takashi;
Sasaki, Tomonari;
Tsubouchi, Hiroshi;
Kakurai, Yasuyuki;
Nishimura, Yasumasa;
Nakagawa, Kazuhiko

Publication type:

journal article

NTRK Fusion-positive Non-small-cell Lung Cancer: The Diagnosis and Targeted Therapy.

Published in:

2021

By:

Haratake, Naoki;
Seto, Takashi

Publication type:

journal article

Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Published in:

2020

By:

Shiraishi, Yoshimasa;
Kishimoto, Junji;
Tanaka, Kentaro;
Sugawara, Shunichi;
Daga, Haruko;
Hirano, Katsuya;
Azuma, Koichi;
Hataji, Osamu;
Hayashi, Hidetoshi;
Tachihara, Motoko;
Mitsudomi, Tetsuya;
Seto, Takashi;
Nakagawa, Kazuhiko;
Yamamoto, Nobuyuki;
Okamoto, Isamu

Publication type:

journal article

Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.

Published in:

2020

By:

Matsubara, Taichi;
Uchi, Hiroshi;
Haratake, Naoki;
Takamori, Shinkichi;
Toyozawa, Ryo;
Miura, Naoko;
Yamaguchi, Masafumi;
Seto, Takashi;
Takenoyama, Mitsuhiro

Publication type:

Case Study

A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

Published in:

2018

By:

Yoshihito Kogure;
Hideo Saka;
Yuichi Takiguchi;
Shinji Atagi;
Takayasu Kurata;
Noriyuki Ebi;
Akira Inoue;
Kaoru Kubota;
Mitsuhiro Takenoyama;
Takashi Seto;
Akiko Kada;
Takeharu Yamanaka;
Masahiko Ando;
Nobuyuki Yamamoto;
Akihiko Gemma;
Yukito Ichinose;
Kogure, Yoshihito;
Saka, Hideo;
Takiguchi, Yuichi;
Atagi, Shinji

Publication type:

journal article

Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).

Published in:

2018

By:

Shinji Atagi;
Junki Mizusawa;
Satoshi Ishikura;
Toshiaki Takahashi;
Hiroaki Okamoto;
Hiroshi Tanaka;
Koichi Goto;
Kazuhiko Nakagawa;
Masao Harada;
Yuichiro Takeda;
Naoyuki Nogami;
Yuka Fujita;
Takashi Kasai;
Kazuma Kishi;
Toshiyuki Sawa;
Koji Takeda;
Keisuke Tomii;
Miyako Satouchi;
Takashi Seto;
Yuichiro Ohe

Publication type:

journal article

Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK Study.

Published in:

2018

By:

Hida, Toyoaki;
Kaji, Reiko;
Satouchi, Miyako;
Ikeda, Norihiko;
Horiike, Atsushi;
Nokihara, Hiroshi;
Seto, Takashi;
Kawakami, Tomohisa;
Nakagawa, Shintaro;
Kubo, Toshio

Publication type:

journal article

The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.

Published in:

2017

By:

Shinkichi Takamori;
Gouji Toyokawa;
Kenichi Taguchi;
Makoto Edagawa;
Shinichiro Shimamatsu;
Ryo Toyozawa;
Kaname Nosaki;
Takashi Seto;
Fumihiko Hirai;
Masafumi Yamaguchi;
Fumihiro Shoji;
Tatsuro Okamoto;
Mitsuhiro Takenoyama;
Yukito Ichinose;
Takamori, Shinkichi;
Toyokawa, Gouji;
Taguchi, Kenichi;
Edagawa, Makoto;
Shimamatsu, Shinichiro;
Toyozawa, Ryo

Publication type:

journal article